Papers

• Judson, MA, An approach to the treatment of pulmonary sarcoidosis with corticosteriods: the six phases of treatment. Chest 1999; 115:1158-1165
  
• Judson MA. Lung Transplantation for Pulmonary Sarcoidosis. Eur Respir J 1998; 11:738-744
  
• Highland KB, Retalis P, Coppage L, Schabel SI, Judson MA. Is there an anatomical explanation for chest pain in patients with pulmonary Sarcoidosis?
  Sou Med J 1997;90:911-914.
  
• Sahn SA, Schwarz MI, Lakshminarayan S. Sarcoidosis: the significance of an acinar pattern on chest roentgenogram. Chest 1974;65:684-687.
  
• Baumann M, Strange C, Sahn SA. The value of the chest radiograph in the assessment of relapse during corticosteriod withdrawl in sarcoidosis. AJR 1990;154:481-485.
  
• Tomlinson JR, Sahn SA. Aspergilloma in sarcoid and tuberculosis. Chest 1987; 92:505-508.
  
• Goodwin JE, Sahn SA. Sarcoidosis presenting as progressive ascending lower extremity weakness and asymptomatic menigitis with hypoglycorrhachia. Chest 1990; 97:1263-1265.
  
• Judson MA, Strange, C. Bullous sarcoidosis: a report of three cases. Chest 1998; 114:1474-1478.
  
• Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H, ACCESS Research Group. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis, Vasc, Diffuse Lung Dis 1999; 16:75-86
  
• Marlow TJ, Krapiva PI, Schabel SI, Judson MA. The "fairy ring": a new radiographic finding in sarcoidosis. Chest 1999;115:275-276
  
• Kajdasz DK, Judson MA,Mohr LC, Lackland DT. Geographic variation in the prevalence of sarcoidosis in South Carolina: its relationship to socioeconomic status and health care indicators. Am J Epidemiol 1999; 150:271-278
  
• Mishra G, Sahai AV, Penman ID, Williams DB, Judson MA, Lewin DN, Hawes RH, Hoffman BJ. Endoscopic ultrasonography with fine needle aspiration: an accurate and simple diagnositc modality for sarcoidosis. Endoscopy 1999; 31:377-382
  
• Judson MA. Clinical aspects of pulmonary sarcoidosis. Journal South Carolina Med Assn 2000; 96:9-17
  
• Kajdasz DK, Lackland DT, Mohr LC, Judson MA. A current assessment of various rurally-linked exposures as potential risk factors for sarcoidosis. Ann Epidemiol 2001; 11:111-117
  
• Chang B, Steimel J, Moller DR, Baughman RP, Judson MA, Yeager H, Teirstein AS, Rossman MD, Rand CS. Depression in sarcoidosis. Am J Respir Crit Care Med 2001; 163:329-334
  
• Judson MA, Uflacker R. Treatment of a solitary pulmonary sarcoidosis mass by CT guided direct itra-lesional injection of corticosteroid. Chest  2001; 120:316-317
  
• Niemer GW, Bolster MB, Buxbaum L, Judson MA. Carpal tunnel syndrome in sarcoidosis. Sarcoidosis, Vasc, Diffuse Lung Dis 2001; 18:296-300
  
• Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager, Jr. H, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885-1889
  
• Rybicki BA, Ianuzzi MC, Frederick MM, Thompson BW, Rossman MD, Breznitz EA, Terrin ML, Moeller DR, Barnard J, Baughman RP, DePalo L, Hunninghake G, Johns C, Judson MA, et al. Familial aggregation of sarcoidosis: a case-control etiology study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164:2085-2091
  
• Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE. Thalidomide for chronic sarcoidosis. Chest 2002; 122:227-232
  
• Baughman RP, Iannuzzi MC, Lower EE, Moeller DR, Balkissoon R, Winget D, Judson MA. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis, Vasc, Diffuse Lung Dis 2002; 19:198-204
  
• Cox, CE, Judson MA,  Donahoe JF, Brown CD. Development of a quality of life measure for persons with sarcoidosis. 7th Annual World Association of Sarcoidosis and Other Granulomatous Dieseases Meeting, Stockholm, Sweden, June 2002
  
• Baughman RP, Judson MA, Teirstein AS, Moller DR, Lower EE. Thalidomide for chronic sarcoidosis.  Chest 2002; 122:227-232
  
• Baughman RP, Iannuzzi MC, Lower EE, Moeller DR, Balkissoon R, Winget D, Judson MA. Use of fluticasone in acute symptomatic pulmonary sarcoidosis. Sarcoidosis, Vasc, Diffuse Lung Dis 2002; 19:198-204
  
• Judson MA. Gastrointestinal, hepatic, and splenic involvement with sarcoidosis.  Semin Respir Crit Care Med 2002; 23:529-541
  
• Heidecker JT, Judson MA. Pleural effusion by trapped lung secondary to sarcoidosis. South Med J 2003; 96:510-511
  
• Judson MA.  The etiologic agent of sarcoidosis: what if ther isn't one? (editorial) Chest 2003;124:6-8
  
• Judson MA, Thompson BW, Rabin DL, Steimel J, Knattereud GL, Lackland DT, Rose C, Rand CS, Baughman RP, Teirsein AS, ACCESS Research Group. The diagnostic pathway to sarcoidosis.  Chest 2003; 123:406-412
  
• Cox CE, Donahoe JF, Brown CD, Kataria YP, Judson MA. The sarcoidosis health questionnaire: a new measure of health-related quality of life for persons with sarcoidosis. Am J Resp Crit Care Med 2003; 168:323-329
  
• Doty JD, Mazur JE, Judson MA. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophospamide regimen. Chest 2003 124:2023-2026
  
• Judson MA, Baughman RP, Thompson BW, Teirstein AS, Terrin ML Rossman MD, Yeager H, McLennan G, Bersnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki BA, Weinberger SE, Knatterud GL, Cherniak R, ACCESS Research Group. Two Year prognosis of sarcoidosis: the ACCESS experience of sarcoidosis, Vasc Diff Lung Dis 2003; 20:204-211
  
• Doty JD, Judson MA. Sarcoidosis, part 1: a thorough look at the clinical aspects. J Respir Dis. 2004;24:31-36
  
• Cox CE, Donahue JF, Brown DC, Kataria YP, Judson MA, Health-related quality of life in persons with sarcoidosis. Chest 2004; 125:997-1004
  
• Doty JD, Judson MA, Sarcoidosis, part 2: confirming the diagnosis and starting treatment. J Respir Dis. 2004;25:120-127
  
• Wildi SM, Judson MA, Fraig M, Fickling WE, Schmulewitz N, Varadarajulu S, Roberts SS, Prasad P, Hawes RH, Wallace MB, Hoffman BJ. Is endosonography guided fine needle aspiration (EUS-FNA) for sarcoidosis as good as we think? Thorax 2004; 59:794-799
  
• Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, Terrin ML, Weinberger SE, Moller DR, McLennan G, Hunninghake G, DePalo L, Baughman RP, Iannuzzi MC, Judson MA, et al., M. A Case Control Etiologic Study of Sarcoidosis:  Environmental and Occupational Risk Factors. Am J Respir Crit Care Med 2004:170:1324-30
  
• Rabin DL, Thompson B, Brown KM, Judson MA, Huang X, Lackland DT, et al. Sarcoidosis: social predictors of severity at presentation. Eur Respir J 2004; 24:601-608
  
• Doty JD, Mazur JE, Judson MA. Treatment of Sarcoidosis with infliximab. Chest 2005;127:1064-1071
  
• Barnard J, Rose C, Newman L, Canner M, Martyny J, McCammon C, Terrin M, Bresnitz E, Rossman M, Thompson B, Rybicki B, Weinberger SE, Moller DR, McLennan G, Hunninghake G, DePalo L, Baughman RP, Iannuzzi MC, Judson MA, Knatterud GL, Teirstein AS, Yeager H, Johns CJ, Rabin DL, Cherniack R, ACCESS Research Group. Job and Industry Classifications Associated with Sarcoidosis in A Case Control Etiologic Study of Sarcoidosis (ACCESS). Journal of Occupational and Environmental Medicine 2005; 47:226-34
  
• Judson MA. Advance for Managers of  Respiratory Care. Making the decision to treat sarcoidosis. 2005; 14: 52-53
  
• Judson MA. Cardiac sarcoidosis: there is no instant replay. Chest 2005; 128:3-6 (editorial)
  
• Yeager H, Rossman MD, Baughman RP, Teirstein AS, Judson MA, Rabin DL, Iannuzzi MC, Rose C, Bresnitz EA, DePalo L, Hunninghake G, Johns* CJ, McLennan G, Moller DR, Newman LS, Rybicki B, Weinberger SE, Wilkins PC, Cherniack R, ACCESS  Research Group. Pulmonary and phychosocial findings at enrollment in the ACCESS study. Sarcoidosis, Vasc Diff Lung Dis 2005; 22:147-53
  
• Iannuzzi MC, Iyengar SK, Gray-McGuire C, Elston, RC, Baughman RP,Donohue JF, Hirst K,  Judson MA, Kavuru MS, Maliarik MJ, Moller DR, Newman LS, Rabin DL, Rossman MD, Teirstein AS, Rybicki BA.  Genome Wide Search for Sarcoidosis Susceptibility Genes in African Americans.  Genes Immun  2005; 6:509-18
  
• Rybicki BA, Hirst K, Iyengar SK, Barnard JG, Judson MA, Rose CS, Donohue JF, Kavuru MS, Rabin DL, Rossman MD, Baughman RP, Elston RC, Maliarik MJ, Moller DR, Newman LS, Teirstein AS, Iannuzzi MC.  A Sarcoidosis Genetic Linkage Consortium:  The Sarcoidosis Genetic Analysis (SAGA) Study.  Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:115-122
  
• Kreider MF, Christie JD, Thompson B, Newman L, Rose C, Barnard J, Bresnitz E, Judson MA, Lackland DT, Rossman MD. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. Chest 2005; 128:207-215
  
• Teirstein AS, Judson MA, Baughman RP, Rossman MD, Yeager H Jr, Moller DR; A Case Control Etiologic Study of Sarcoidosis (ACCESS) Writing Group. The spectrum of biopsy sites for the diagnosis of sarcoidosis. Sarcoidosis Vasc Diff Lung Dis 2005; 22:139-46
  
• Judson MA, Silvestri J, Hartung C, Byars T, Cox CE. The Effect of Thalidomide on Corticosteroid-dependent Pulmonary Sarcoidosis. Sarcoidosis Vasc Diff Lung Dis (in press)
  
• Wasfi YS, Rose CS, Murphy JR, Silveira LJ, Grutters JC, Inoue Y, Judson MA, Maier LA. A New Tool to Assess Sarcoidosis Severity. Chest (in press)

Letters

• Judson MA, Ghent S, Close TP. Sarcoidosis presenting as peripheral pulmonary infiltrates.
  AJR 1993;160:1359-1360.

Abstracts

• Retalis P, Coppage L, Schabel SI, Judson MA. Symptoms in sarcoidosis: what do they mean? Am J Respir Crit Care Med 1995;151(4, part 2):a595.
  
• Winget DB, Judson MA, Moller DR, Baughman RP. Relationship between cough, airway obstruction, and methacholine challenge in sarcoidosis. Am J Respir Crit Care Med 1999;159(3, part 2):A830
  
• Lower EE, Winget DB, Judson MA, Moeller DR, Teirstein AS, Baughman RP. Thalidomide for chronic sarcoidosis. Sarcoidosis, Vasc, Diffuse Lung Dis 1999; 16(suppl N1):40
  
• Judson MA, Moller D, Newman L, Rossman M, Teirstein A, ACCESS Reasearch Group. A Case Control Etiologic Study of Sarcoidosis (ACCESS). Sarcoidosis Vasc Diff Lung Dis 1999; 16(suppl N1):7
  
• Niemer GW, Bolster MB, Judson MA. Carpel tunnel syndrome in sarcoidosis. Am J Respir Crit Care Med 2000; 161(3, part 2):A264
  
• Chang B, Steimel J, Moller DR, Baughman RP, Judson MA, Yeager H, Teirstein AS, Rossman MD, Rand C. Depression in sarcoidosis. Am J Respir Crit Care Med 2000;161(3, part 2):A265
  
• Winget DB, Judson MA, Moller DR, Ianuzzi MC, Balkisson R, Newman LS, Baughman RP. Compliance to a steroid reduction protocol guideline for sarcoidosis. Am J Respir Crit Care Med 2000;161(3, part 2):A267
  
• Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H. Extrapulmonary sarcoidosis: presence at presentation is related to age, gender, and race. Am J Respir Crit Care Med 2001; 163 (5, part 2):A958
  
• Judson MA, Thompson B, Rabin D, Steimel J, Knattereud G, Lackland D, and the ACCESS Research Group. Diagnostic pathway to sarcoidosis. Am J Respir Crit Care Med 2001; 163 (5, part 2):A958  
  
• Teirstein AS, Judson MA, Baughman RP, Rossman MD, Yeager H, Terrin M, ACCESS Research Group. The spectrum of biopsy sites in 736 cases of sarcoidosis presenting in ACCESS. Am J Respir Crit Care Med 2002; 165(8):A493
  
• Judson MA, Baughman RP, Rossman MD, Yeager H, Teirstein AS, Gnatterud GL, ACCESS Reasearch Group. Two-year prognosis of sarcoidosis: the ACCESS experience. Am J Respir Crit Care Med 2002; 165(8):A495
  
• Baughman RP, Judson MA, Teirstein AS, Yeager H, Rossman MD, Gnatterud GL, ACCESS Research Group. Corticosteroid therapy during two years after initial diagnosis of sarcoidosis: results of ACCESS. Am J Respir Crit Care Med 2002; 165(8):A495
  
• Yeager H, Rossman MD, Terrin ML, Teirstein AS, Judson MA, Baughman RP, ACCESS Research Group. Radiographic changes, spirometry, and dyspnea onset in ACCESS. 7th Annual World Association of Sarcoidosis and Other Granulomatous Diseases Meeting, Stockholm, Sweden, June 2002
  
• Baughman RP, Judson MA, Teirstein AS, Yeager H, Rossman MD, Knattereud GL, ACCESS Research Group. The eeffect of race, age, gender on the need for corticosteroid therapy in sarcoidosis. 7th Annual World Association of Sarcoidosis and Other Granulomatous Diseases Meeting, Stockholm, Sweden, June 2002
  
• Cox, CE, Donahoe JF, Brown CD, Kataria YP, Judson MA. Development and early validation of sarcoidosis health questionnaire: a new measure of health-related quality of life fore persons with sarcoidosis. Am J Respir Crit Care Med 2003; 167 (7, part 2): A37
  
• Baughman RP, Drent M, Rizzato G, Judson MA, Nagai S, Costabel U, du Bois R. Proposed clinical phenotype of sarcoidosis. Am J Respir Crit Care Med 2003; 167 (7, part 2): A170
  
• Stephan M. Wildi, Marc Judson, William E. Fickling, Nathan Schmulewitz, Shyam Varadrajulu, Stacey S. Roberts, Brenda Ferguson, Robert H. Hawes, Michael B. Wallace, Brenda J. Hoffman. Is EUS-FNA for sarcoidosis as good as we think? Gastrointest Endosc 2003;57:AB241
  
• Baughman RP, Drent M, du Bois R, Spangnolo P, Grutters JC, Sato H, Teirsein AS, Nagai S, Judson MA. The Effect of Race, Age and Gender on Clinical Outcome in Sarcoidosis. Am J Resp Crit Care Med 2004; 169:A33
  
• Huggins JT, Judson MA,  Sahn SA, Doelken P, King LB. The Prevalence of Pleural Effusion in Sarcoidosis as Defined by Ultrasonography. Am J Resp Crit Care Med 2004; 169:A33
  
• Baughman RP, Judson MA, Lower EE, Schkenker-Herceg R. Lupus pernio activity and severity index (LUPASI) score in sarcoidosis patients. Chest 2004; 126 (4)suppl:891S
  
• Baughman RP, EE Lower EE, Judson MA, Teirstein A, Schlenker-Herceg R, Barnathan E. Lupus pernio in sarcoidosis: Clinical features and a target for therapy. Am J Respir Crit Care Med 2005; 171: A862
  
• Judson MA, Silvestri J, Byars TR, Cox CE. The treatment of corticosteroid-dependent pulmonary sarcoidosis with thalidomide. Am J Respir Crit Care Med 2005; 171: A18
  
• Bagg SA, Gordon LL, Judson MA. Diagnostic yield of non invasive tests for cardiac sarcoidosis. Am J Respir Crit Care Med 2005; 171: A864
  
• Baughman RP, Judson MA, Costabel U, duBois RM, Drent M, Kavuru M, Lo KH, Andresen C, Schlenker-Herceg R, Barnathan E. Randomized, double-blind, placebo-controlled trial of infliximab in patients with chronic pulmonary sarcoidosis. Chest 2005; 128(4):S202
  
• Judson MA, Costabel U, Drent M, Kavuru M, duBois RM, Lo KH, Schlenker-Herceg R, Barnathan, E Baughman RP. Assessment of infliximab efficacy in extrapulmonary sarcoidosis using a novel assessment tool: results from a randomized trial. Chest 2005; 128(4):S202
  
• Drent M, Judson MA, Costabel U, duBois RM, Kavuru M, Lo KH,  Andresen C, Schlenker-Herceg R, Barnathan E, Baughman RP. Responder analysis in patients receiving infliximab for chronic sarcoidosis with pulmonary involvement. Chest 2005 128(4):S316

Book and Monograph Chapters

• Judson MA. Extrapulmonary sarciodosis. Pulmonary and Critical Care Update 1999; 13(12):1-14
  
• Judson MA, Baughman RP. Sarcoidosis.In: Baughman RP, DuBois RM, Lynch JP (eds). Diffuse Lung Disease, A Practical Approach. Arnold Publishers, London 2004. pp109-129
  
• Judson MA. Hepatic and splenic sarcoidosis. In: Sarcoidosis.Lung Biology in Health and Disease. New York: Marcel Dekker. 2005; 10:32:188-209
  
• Judson MA.  Lung Transplantation for sarcoidosis. In: Sarcoidosis. Lung Biology in Health and Disease. New York: Marcel Dekker. (in press)
  
• Ohara K, Judson MA, Baughman RP. Clinical aspects of ocular sarcoidosis. European Respiratory Journal Monograph 2005; 10:188-209
  
• Judson MA. Sarcoidosis. Pulmonary and Critical Care Secrets (in press)
  
• Judson MA. Sarcoidosis. Conn’s Therapy. (in press)
  

disclaimer